Underhill Investment Management Has Decreased Core Laboratories N V (CLB) Holding; GRUMA SAB DE CV (GPAGF) Shorts Decreased By 7.84%

January 15, 2018 - By Richard Conner

GRUMA SAB DE CV (OTCMKTS:GPAGF) had a decrease of 7.84% in short interest. GPAGF’s SI was 887,800 shares in January as released by FINRA. Its down 7.84% from 963,300 shares previously. With 800 avg volume, 1110 days are for GRUMA SAB DE CV (OTCMKTS:GPAGF)’s short sellers to cover GPAGF’s short positions. It closed at $12.6952 lastly. It is down 0.00% since January 15, 2017 and is . It has underperformed by 16.70% the S&P500.

Underhill Investment Management Llc decreased Core Laboratories N V (CLB) stake by 27.29% reported in 2017Q3 SEC filing. Underhill Investment Management Llc sold 15,935 shares as Core Laboratories N V (CLB)’s stock declined 4.78%. The Underhill Investment Management Llc holds 42,460 shares with $4.19M value, down from 58,395 last quarter. Core Laboratories N V now has $5.26 billion valuation. The stock increased 0.09% or $0.11 during the last trading session, reaching $119.1. About 318,286 shares traded. Core Laboratories N.V. (NYSE:CLB) has declined 5.82% since January 15, 2017 and is downtrending. It has underperformed by 22.52% the S&P500.

Gruma, S.A.B. de C.V., through its subsidiaries, produces and sells corn flour, tortillas, and other related products. The company has market cap of $5.85 billion. The firm offers corn and wheat flour tortillas; tortilla chips; flatbreads, including pita, naan, chapati, pizza bases, and piadina; hearts of palm; rice; wraps, corn and potato chips, salsas, and processed foods; and breakfast cereals and polenta. It has a 17.3 P/E ratio. It markets and sells its products under the MASECA, TORTIMASA, MASARICA, MINSA, JUANA, MIMASA, TORTIRICAS, MISSION, TOSTY, RUMBA, BRAVOS, TRONADITAS, GUERRERO, CALIDAD, MEXIFOODS, and DELICADOS brand names.

Investors sentiment decreased to 1.07 in Q3 2017. Its down 0.01, from 1.08 in 2017Q2. It worsened, as 45 investors sold CLB shares while 99 reduced holdings. 42 funds opened positions while 112 raised stakes. 49.25 million shares or 6.07% more from 46.43 million shares in 2017Q2 were reported. Eaton Vance Mngmt has 438,640 shares for 0.11% of their portfolio. Texas Permanent School Fund reported 32,202 shares stake. Gsa Cap Llp has 4,863 shares. Stephens Inc Ar reported 0.01% of its portfolio in Core Laboratories N.V. (NYSE:CLB). Burt Wealth Advsrs has invested 0% in Core Laboratories N.V. (NYSE:CLB). Eqis Management holds 0.03% or 5,311 shares in its portfolio. Lombard Odier Asset Mgmt (Switzerland) Sa invested in 12,883 shares. Eagle Asset Mngmt Inc reported 0.03% of its portfolio in Core Laboratories N.V. (NYSE:CLB). Wellington Management Gru Llp holds 0.01% or 356,444 shares. Thrivent Fincl For Lutherans has invested 0% in Core Laboratories N.V. (NYSE:CLB). Ariel Investments Limited Liability Company invested in 452,481 shares. Van Eck Assocs Corp has 574,026 shares for 0.29% of their portfolio. Northwestern Mutual Wealth Mngmt invested in 895 shares. Asset One Company, Japan-based fund reported 64,147 shares. Shelter Ins Retirement Plan stated it has 1.2% in Core Laboratories N.V. (NYSE:CLB).

Among 23 analysts covering Core Laboratories (NYSE:CLB), 12 have Buy rating, 0 Sell and 11 Hold. Therefore 52% are positive. Core Laboratories had 51 analyst reports since August 24, 2015 according to SRatingsIntel. The firm has “Neutral” rating given on Wednesday, September 30 by Sterne Agee CRT. The stock of Core Laboratories N.V. (NYSE:CLB) has “Neutral” rating given on Tuesday, December 13 by UBS. On Tuesday, April 19 the stock rating was maintained by Morgan Stanley with “Overweight”. KLR Group initiated Core Laboratories N.V. (NYSE:CLB) on Monday, December 14 with “Buy” rating. As per Monday, August 7, the company rating was maintained by Morgan Stanley. ABN Amro upgraded the shares of CLB in report on Wednesday, October 25 to “Buy” rating. The rating was maintained by UBS with “Neutral” on Wednesday, October 25. The stock of Core Laboratories N.V. (NYSE:CLB) earned “Hold” rating by Cowen & Co on Friday, October 6. The stock of Core Laboratories N.V. (NYSE:CLB) earned “Market Perform” rating by Cowen & Co on Monday, October 26. The rating was initiated by Tudor Pickering with “Hold” on Friday, March 24.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.